Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Magnachem Pharmaceuticals Private Limite D, was an unlisted private company incorporated on 30 August, 1980. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital was INR 1.00 cr and the total paid-up capital was INR 81.40 lac.
The current status of Magnachem Pharmaceuticals Private Limite D is - Strike Off.
Read more
** All rupee values in INR crores.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Gautam Premnath Khandelwal | 00270717 | 31 years |
| Director | Suelve Gautam Khandelwal | 00270811 | 28 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ZEPPELIN INVESTMENTS PRIVATE LIMITED |
Active
|
55.9 L | 2 | Maharashtra |
| KHANDELWAL REMEDIES P LTD |
Strike Off
|
2.1 L | 2 | Maharashtra |
| GRAS EDUCATION & TRAINING SERVICES PRIVATE LIMITED |
Active
|
3.6 Cr | 1 | Delhi |
| TESTDATA TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| ENTECRES LABS PRIVATE LIMITED |
Active
|
1.7 L | 1 | Delhi |
| MOTWANE DIGITAL PRIVATE LIMITED |
Active
|
1.0 L | 2 | |
| MOTWANE BUILDING SYSTEMS PRIVATE LIMITED |
Active
|
1.0 L | 1 | |
| INFORMED TECHNOLOGIES INDIA LIMITED |
Active
|
4.2 Cr | 1 | |
| NAGPUR POWER AND INDUSTRIES LIMITED |
Active
|
13.1 Cr | 1 | Maharashtra |
| THE MOTWANE MANUFACTURING COMPANY PRIVATE LIMITED |
Active
|
9.5 Cr | 1 | Maharashtra |
| VARROC POLYMERS LIMITED |
Amalgamated
|
52.9 L | 1 | Maharashtra |
| TYPEOUT MEDIA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
Read more
The incorporation date of MAGNACHEM PHARMACEUTICALS PRIVATE LIMITE D is 30 August, 1980
The authorized share capital of MAGNACHEM PHARMACEUTICALS PRIVATE LIMITE D is INR ₹ 1.0 Cr.
The paid-up capital of MAGNACHEM PHARMACEUTICALS PRIVATE LIMITE D is INR ₹ 81.4 L.
The registered address of MAGNACHEM PHARMACEUTICALS PRIVATE LIMITE D is PLOT NO M-4ADDITINAL MIDC SATARA Maharashtra - 415004
The CIN number of MAGNACHEM PHARMACEUTICALS PRIVATE LIMITE D is U24239MH1980PTC023041.